IndexIQ Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$8.51M Sell
48,009
-16,583
-26% -$2.82M 0.3% 70
2021
Q4
$11M Sell
64,592
-529
-0.8% -$86.6K 0.37% 48
2021
Q3
$10.5M Buy
65,121
+2,077
+3% +$354K 0.35% 55
2021
Q2
$10.4M Buy
63,044
+1,064
+2% +$176K 0.35% 52
2021
Q1
$10.2M Buy
61,980
+10,653
+21% +$1.72M 0.36% 50
2020
Q4
$8.08M Buy
51,327
+17,231
+51% +$2.54M 0.3% 55
2020
Q3
$5.08M Buy
34,096
+11,757
+53% +$1.74M 0.21% 64
2020
Q2
$3.14M Buy
22,339
+6,580
+42% +$959K 0.14% 83
2020
Q1
$2.07M Buy
15,759
+14,841
+1,617% +$2.11M 0.1% 96
2019
Q4
$134K Buy
+918
New +$125K ﹤0.01% 500

Other funds holding JNJ

IndexIQ Advisors's JNJ Position: Q1 2022 in Review

IndexIQ Advisors reduced its Johnson & Johnson (JNJ) stake by 26% in Q1 2022, selling an estimated $2.82M and leaving 48,009 shares worth $8.51M. The position accounts for 0.3% of the portfolio, ranked #70.

IndexIQ Advisors first reported a position in JNJ in Q4 2019 and has held it in 10 quarters since. The position peaked at $11M in Q4 2021. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • IndexIQ Advisors held 48,009 shares of Johnson & Johnson worth $8.51M as of Q1 2022.
  • IndexIQ Advisors sold 16,583 Johnson & Johnson shares in Q1 2022, an estimated $2.82M.
  • Johnson & Johnson made up 0.3% of IndexIQ Advisors's portfolio in Q1 2022, its #70 holding.
  • IndexIQ Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's Johnson & Johnson position peaked at $11M in Q4 2021.
  • 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.